grant
saveJANUSQ, LLC — In vivo efficacy and in vitro toxicity assessment of peptide-based therapy HV...
September 15, 2025updated 2mo ago
community read0 votes
NS grant. $490,501. PI: Andrew Loring Schilb
view source ↗NS grant. $490,501. PI: Andrew Loring Schilb
view source ↗
comments(0)
5-min edit window · permanent after that